Skip to main content
. 2013 Mar 8;11:60. doi: 10.1186/1479-5876-11-60

Figure 3.

Figure 3

Kaplan-Meier survival analysis in patients with metastatic/recurrent ESCC. Disease-free survival and overall survival curves for metastatic/recurrent ESCC patients with low and high expression levels of MIF in tumor cells (a and b). Disease-free survival and overall survival curves for metastatic/recurrent ESCC patients with low and high expression levels of CXCR4 in tumor cells (c and d).

HHS Vulnerability Disclosure